VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q54185781 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010723.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q54185781‏
024 ‎‡a 0000-0001-6104-9113‏ ‎‡2 orcid‏
024 ‎‡a 7203063281‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q54185781‏
100 0 ‎‡a Roberto Costa‏ ‎‡c researcher (ORCID 0000-0001-6104-9113)‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Roberto Costa‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS‏
670 ‎‡a Author's A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy.‏
670 ‎‡a Author's Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association‏
670 ‎‡a Author's COMBAT-conventional versus multisite pacing for bradyarrhythmia therapy: rationale of a prospective randomized multicenter study‏
670 ‎‡a Author's Complications after Surgical Procedures in Patients with Cardiac Implantable Electronic Devices: Results of a Prospective Registry‏
670 ‎‡a Author's Conventional Versus Biventricular Pacing in Heart Failure and Bradyarrhythmia: The COMBAT Study‏
670 ‎‡a Author's Criteria for Pacemaker Explant in Patients Without a Precise Indication for Pacemaker Implantation‏
670 ‎‡a Author's Cryosurgical ablation of fetal atrioventricular node: new model to treat fetal malignant tachyarrhythmias‏
670 ‎‡a Author's Dura mater valve endocarditis related to retained fragment of postoperative temporary epicardial pacemaker lead‏
670 ‎‡a Author's Effects of Cardiac Resynchronization Therapy on Muscle Sympathetic Nerve Activity‏
670 ‎‡a Author's Effects of the association of dual-site dynamic atrial overdrive and atenolol in preventing recurrent atrial fibrillation.‏
670 ‎‡a Author's Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial‏
670 ‎‡a Author's Evolution of cardiovascular surgery at the Instituto do Coração: analysis of 71,305 surgeries‏
670 ‎‡a Author's Fetal heart block: a new experimental model to assess fetal pacing.‏
670 ‎‡a Author's Functional capacity of patients with pacemaker due to isolated congenital atrioventricular block‏
670 ‎‡a Author's ICD patients with elevated defibrillation threshold: clinical behavior and therapeutic alternatives.‏
670 ‎‡a Author's Images in cardiovascular medicine. Endocarditis secondary to microsporidia: giant vegetation in a pacemaker user‏
670 ‎‡a Author's Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study.‏
670 ‎‡a Author's Laser assisted extraction of pacemaker and implantable defibrillator leads.‏
670 ‎‡a Author's Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.‏
670 ‎‡a Author's Minimally Invasive Epicardial Pacemaker Implantation in Neonates with Congenital Heart Block‏
670 ‎‡a Author's New lead for in utero pacing for fetal congenital heart block‏
670 ‎‡a Author's Novel approach to epicardial pacemaker implantation in patients with limited venous access‏
670 ‎‡a Author's Pacemaker-related infection detected by (18)F-fluorodeoxyglucose positron emission tomography-computed tomography.‏
670 ‎‡a Author's Predictors of Arrhythmic Events Detected by Implantable Loop Recorders in Renal Transplant Candidates.‏
670 ‎‡a Author's Predictors of death in chronic Chagas cardiomyopathy patients with pacemaker.‏
670 ‎‡a Author's Prevention of venous thrombosis by warfarin after permanent transvenous leads implantation in high-risk patients.‏
670 ‎‡a Author's Response to Letter Regarding Article, “Endocarditis Secondary to Microsporidia: Giant Vegetation in a Pacemaker User” ‏
670 ‎‡a Author's Successful endomyocardial biopsy guided by transthoracic two-dimensional echocardiography.‏
670 ‎‡a Author's Transfemoral Pediatric Permanent Pacing:. Long-term Results‏
670 ‎‡a Author's Unscheduled Return Visits to the Emergency Department after Cardiac Electronic Devices Implantation.‏
670 ‎‡a Author's Upgrading from VVI to DDD pacing Mode during elective replacement of pulse generator: a comparative clinical-functional analysis.‏
670 ‎‡a Author's Usefulness of preoperative venography in patients with cardiac implantable electronic devices submitted to lead replacement or device upgrade procedures‏
909 ‎‡a (scopus) 7203063281‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000161049113‏ ‎‡9 1‏
919 ‎‡a predictorsofarrhythmiceventsdetectedbyimplantablelooprecordersinrenaltransplantcandidates‏ ‎‡A Predictors of Arrhythmic Events Detected by Implantable Loop Recorders in Renal Transplant Candidates.‏ ‎‡9 1‏
919 ‎‡a usefulnessofpreoperativevenographyinpatientswithcardiacimplantableelectronicdevicessubmittedtoleadreplacementordeviceupgradeprocedures‏ ‎‡A Usefulness of preoperative venography in patients with cardiac implantable electronic devices submitted to lead replacement or device upgrade procedures‏ ‎‡9 1‏
919 ‎‡a upgradingfromvvitodddpacingmodeduringelectivereplacementofpulsegeneratoracomparativeclinicalfunctionalanalysis‏ ‎‡A Upgrading from VVI to DDD pacing Mode during elective replacement of pulse generator: a comparative clinical-functional analysis.‏ ‎‡9 1‏
919 ‎‡a unscheduledreturnvisitstotheemergencydepartmentaftercardiacelectronicdevicesimplantation‏ ‎‡A Unscheduled Return Visits to the Emergency Department after Cardiac Electronic Devices Implantation.‏ ‎‡9 1‏
919 ‎‡a transfemoralpediatricpermanentpacinglongtermresults‏ ‎‡A Transfemoral Pediatric Permanent Pacing:. Long-term Results‏ ‎‡9 1‏
919 ‎‡a successfulendomyocardialbiopsyguidedbytransthoracic2dimensionalechocardiography‏ ‎‡A Successful endomyocardial biopsy guided by transthoracic two-dimensional echocardiography.‏ ‎‡9 1‏
919 ‎‡a responsetoletterregardingarticleendocarditissecondarytomicrosporidiagiantvegetationinapacemakeruser‏ ‎‡A Response to Letter Regarding Article, “Endocarditis Secondary to Microsporidia: Giant Vegetation in a Pacemaker User” ‏ ‎‡9 1‏
919 ‎‡a preventionofvenousthrombosisbywarfarinafterpermanenttransvenousleadsimplantationinhighriskpatients‏ ‎‡A Prevention of venous thrombosis by warfarin after permanent transvenous leads implantation in high-risk patients.‏ ‎‡9 1‏
919 ‎‡a predictorsofdeathinchronicchagascardiomyopathypatientswithpacemaker‏ ‎‡A Predictors of death in chronic Chagas cardiomyopathy patients with pacemaker.‏ ‎‡9 1‏
919 ‎‡a pacemakerrelatedinfectiondetectedby18ffluorodeoxyglucosepositronemissiontomographycomputedtomography‏ ‎‡A Pacemaker-related infection detected by (18)F-fluorodeoxyglucose positron emission tomography-computed tomography.‏ ‎‡9 1‏
919 ‎‡a novelapproachtoepicardialpacemakerimplantationinpatientswithlimitedvenousaccess‏ ‎‡A Novel approach to epicardial pacemaker implantation in patients with limited venous access‏ ‎‡9 1‏
919 ‎‡a newleadforinuteropacingforfetalcongenitalheartblock‏ ‎‡A New lead for in utero pacing for fetal congenital heart block‏ ‎‡9 1‏
919 ‎‡a minimallyinvasiveepicardialpacemakerimplantationinneonateswithcongenitalheartblock‏ ‎‡A Minimally Invasive Epicardial Pacemaker Implantation in Neonates with Congenital Heart Block‏ ‎‡9 1‏
919 ‎‡a longtermfollowupofimplantablecardioverterdefibrillatorforsecondarypreventioninchagasheartdisease‏ ‎‡A Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.‏ ‎‡9 1‏
919 ‎‡a laserassistedextractionofpacemakerandimplantabledefibrillatorleads‏ ‎‡A Laser assisted extraction of pacemaker and implantable defibrillator leads.‏ ‎‡9 1‏
919 ‎‡a incidenceandriskfactorsofupperextremitydeepveinlesionsafterpermanenttransvenouspacemakerimplanta6monthfollowupprospectivestudy‏ ‎‡A Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study.‏ ‎‡9 1‏
919 ‎‡a imagesincardiovascularmedicineendocarditissecondarytomicrosporidiagiantvegetationinapacemakeruser‏ ‎‡A Images in cardiovascular medicine. Endocarditis secondary to microsporidia: giant vegetation in a pacemaker user‏ ‎‡9 1‏
919 ‎‡a icdpatientswithelevateddefibrillationthresholdclinicalbehaviorandtherapeuticalternatives‏ ‎‡A ICD patients with elevated defibrillation threshold: clinical behavior and therapeutic alternatives.‏ ‎‡9 1‏
919 ‎‡a functionalcapacityofpatientswithpacemakerduetoisolatedcongenitalatrioventricularblock‏ ‎‡A Functional capacity of patients with pacemaker due to isolated congenital atrioventricular block‏ ‎‡9 1‏
919 ‎‡a fetalheartblockanewexperimentalmodeltoassessfetalpacing‏ ‎‡A Fetal heart block: a new experimental model to assess fetal pacing.‏ ‎‡9 1‏
919 ‎‡a evolutionofcardiovascularsurgeryattheinstitutodocoracaoanalysisof71305surgeries‏ ‎‡A Evolution of cardiovascular surgery at the Instituto do Coração: analysis of 71,305 surgeries‏ ‎‡9 1‏
919 ‎‡a efficacyofantibioticprophylaxisbeforetheimplantationofpacemakersandcardioverterdefibrillatorsresultsofalargeprospectiverandomizeddoubleblindedplacebocontrolledtrial‏ ‎‡A Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial‏ ‎‡9 1‏
919 ‎‡a effectsoftheassociationofdualsitedynamicatrialoverdriveandatenololinpreventingrecurrentatrialfibrillation‏ ‎‡A Effects of the association of dual-site dynamic atrial overdrive and atenolol in preventing recurrent atrial fibrillation.‏ ‎‡9 1‏
919 ‎‡a effectsofcardiacresynchronizationtherapyonmusclesympatheticnerveactivity‏ ‎‡A Effects of Cardiac Resynchronization Therapy on Muscle Sympathetic Nerve Activity‏ ‎‡9 1‏
919 ‎‡a duramatervalveendocarditisrelatedtoretainedfragmentofpostoperativetemporaryepicardialpacemakerlead‏ ‎‡A Dura mater valve endocarditis related to retained fragment of postoperative temporary epicardial pacemaker lead‏ ‎‡9 1‏
919 ‎‡a cryosurgicalablationoffetalatrioventricularnodenewmodeltotreatfetalmalignanttachyarrhythmias‏ ‎‡A Cryosurgical ablation of fetal atrioventricular node: new model to treat fetal malignant tachyarrhythmias‏ ‎‡9 1‏
919 ‎‡a criteriaforpacemakerexplantinpatientswithoutapreciseindicationforpacemakerimplantation‏ ‎‡A Criteria for Pacemaker Explant in Patients Without a Precise Indication for Pacemaker Implantation‏ ‎‡9 1‏
919 ‎‡a conventionalversusbiventricularpacinginheartfailureandbradyarrhythmiathecombatstudy‏ ‎‡A Conventional Versus Biventricular Pacing in Heart Failure and Bradyarrhythmia: The COMBAT Study‏ ‎‡9 1‏
919 ‎‡a complicationsaftersurgicalproceduresinpatientswithcardiacimplantableelectronicdevicesresultsofaprospectiveregistry‏ ‎‡A Complications after Surgical Procedures in Patients with Cardiac Implantable Electronic Devices: Results of a Prospective Registry‏ ‎‡9 1‏
919 ‎‡a combatconventionalversusmultisitepacingforbradyarrhythmiatherapyrationaleofaprospectiverandomizedmulticenterstudy‏ ‎‡A COMBAT-conventional versus multisite pacing for bradyarrhythmia therapy: rationale of a prospective randomized multicenter study‏ ‎‡9 1‏
919 ‎‡a clinicalpracticeandimplementationofguidelinesforthepreventiondiagnosisandmanagementofcardiacimplantableelectronicdeviceinfectionsresultsofaworldwidesurveyundertheauspicesoftheeuropeanheartrhythmassociation‏ ‎‡A Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association‏ ‎‡9 1‏
919 ‎‡a cohortstudyofcardiacresynchronizationtherapyinpatientswithchronicchagascardiomyopathy‏ ‎‡A A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy.‏ ‎‡9 1‏
919 ‎‡a 2018ehraexpertconsensusstatementonleadextractionrecommendationsondefinitionsendpointsresearchtrialdesignanddatacollectionrequirementsforclinicalscientificstudiesandregistriesendorsedbyaphrshrslahrs‏ ‎‡A 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 PTBNP|97739‏
996 ‎‡2 LC|n 83007351‏
996 ‎‡2 LC|no2011070158‏
996 ‎‡2 BLBNB|000376120‏
996 ‎‡2 BLBNB|000486506‏
996 ‎‡2 LC|no2019116972‏
996 ‎‡2 BLBNB|001509757‏
996 ‎‡2 PTBNP|277060‏
996 ‎‡2 BLBNB|000167981‏
996 ‎‡2 ISNI|0000000500869790‏
996 ‎‡2 DNB|1067771085‏
996 ‎‡2 PLWABN|9812836691205606‏
996 ‎‡2 LC|n 2019012593‏
996 ‎‡2 BLBNB|000449139‏
996 ‎‡2 SUDOC|24493522X‏
996 ‎‡2 SUDOC|233090894‏
996 ‎‡2 BLBNB|001117816‏
996 ‎‡2 NTA|070296049‏
996 ‎‡2 NUKAT|n 2004023750‏
996 ‎‡2 DNB|1157051081‏
996 ‎‡2 PLWABN|9812620180405606‏
996 ‎‡2 ISNI|0000000123990324‏
996 ‎‡2 LC|nr 97009416‏
996 ‎‡2 BLBNB|000558517‏
996 ‎‡2 SUDOC|196885221‏
996 ‎‡2 LC|n 2010202890‏
996 ‎‡2 BLBNB|000404861‏
996 ‎‡2 LC|no2019145492‏
996 ‎‡2 LC|n 87103892‏
996 ‎‡2 ISNI|0000000069911815‏
996 ‎‡2 ISNI|0000000021622942‏
996 ‎‡2 ISNI|0000000058229386‏
996 ‎‡2 ISNI|0000000068311914‏
996 ‎‡2 DNB|13435138X‏
996 ‎‡2 LC|n 84157477‏
996 ‎‡2 NKC|xx0093997‏
996 ‎‡2 LC|n 86078144‏
996 ‎‡2 NSK|000784018‏
996 ‎‡2 NDL|031894548‏
996 ‎‡2 NTA|243206755‏
996 ‎‡2 LC|no2001082191‏
996 ‎‡2 RERO|A006121290‏
996 ‎‡2 BLBNB|001473950‏
996 ‎‡2 BLBNB|000383414‏
996 ‎‡2 ISNI|0000000069121223‏
996 ‎‡2 DNB|17338644X‏
996 ‎‡2 ISNI|0000000022851886‏
996 ‎‡2 SUDOC|230050670‏
996 ‎‡2 BLBNB|000209351‏
996 ‎‡2 NTA|407437789‏
996 ‎‡2 DE633|pe40220311‏
996 ‎‡2 BLBNB|001573643‏
996 ‎‡2 BLBNB|001472393‏
996 ‎‡2 DNB|123259029‏
996 ‎‡2 ISNI|0000000030789031‏
996 ‎‡2 LC|n 00002387‏
996 ‎‡2 BLBNB|000560861‏
996 ‎‡2 DNB|1214683819‏
996 ‎‡2 BIBSYS|1633429906383‏
996 ‎‡2 BNC|981059747305806706‏
996 ‎‡2 BLBNB|001535320‏
996 ‎‡2 ISNI|0000000388087376‏
996 ‎‡2 RERO|A000044546‏
996 ‎‡2 ISNI|0000000107574662‏
996 ‎‡2 PTBNP|171565‏
996 ‎‡2 PLWABN|9810565170905606‏
996 ‎‡2 PLWABN|9812681787805606‏
996 ‎‡2 CAOONL|ncf10173236‏
996 ‎‡2 LC|no 00013984‏
996 ‎‡2 BLBNB|000609878‏
996 ‎‡2 NUKAT|n 2017168241‏
996 ‎‡2 ARBABN|000047517‏
996 ‎‡2 LC|n 87935570‏
996 ‎‡2 BLBNB|000606634‏
996 ‎‡2 NKC|jo20221152015‏
996 ‎‡2 BLBNB|001025412‏
996 ‎‡2 LC|n 92065501‏
996 ‎‡2 NUKAT|n 2021025882‏
996 ‎‡2 PTBNP|541624‏
996 ‎‡2 J9U|987010928886905171‏
996 ‎‡2 LC|no2006010461‏
996 ‎‡2 RERO|A014231527‏
996 ‎‡2 BLBNB|000167974‏
996 ‎‡2 BLBNB|000320582‏
996 ‎‡2 SUDOC|117774480‏
996 ‎‡2 LC|no2022113033‏
996 ‎‡2 SUDOC|26215336X‏
996 ‎‡2 BLBNB|000435011‏
996 ‎‡2 BNC|981060536864606706‏
996 ‎‡2 ISNI|0000000437145203‏
996 ‎‡2 LC|n 2014206465‏
996 ‎‡2 NTA|269105328‏
996 ‎‡2 SUDOC|275897176‏
996 ‎‡2 BLBNB|000498471‏
996 ‎‡2 BLBNB|000355813‏
996 ‎‡2 SUDOC|061331066‏
996 ‎‡2 BLBNB|000167979‏
996 ‎‡2 LC|n 93903895‏
996 ‎‡2 BIBSYS|39353‏
996 ‎‡2 ISNI|0000000069923330‏
996 ‎‡2 BLBNB|000167977‏
996 ‎‡2 BLBNB|000405814‏
996 ‎‡2 BLBNB|000167975‏
996 ‎‡2 ISNI|0000000025244379‏
996 ‎‡2 LC|n 78042592‏
996 ‎‡2 NTA|148970184‏
996 ‎‡2 PLWABN|9810615456005606‏
996 ‎‡2 ICCU|UBOV987236‏
996 ‎‡2 LC|no2020079349‏
996 ‎‡2 W2Z|1633429906383‏
996 ‎‡2 NII|DA07245083‏
996 ‎‡2 DNB|1243218843‏
996 ‎‡2 LIH|LNB:B_v_9_w_;=CI‏
996 ‎‡2 ISNI|0000000082265774‏
996 ‎‡2 ISNI|0000000081592685‏
996 ‎‡2 J9U|987007419523805171‏
996 ‎‡2 BNF|17736206‏
996 ‎‡2 J9U|987007434383905171‏
996 ‎‡2 DNB|171102819‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏